|Detection of circulating tumor DNA in early-and late-stage human malignancies|
C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...
Science translational medicine 6 (224), 224ra24-224ra24, 2014
|Detection and localization of surgically resectable cancers with a multi-analyte blood test|
JD Cohen, L Li, Y Wang, C Thoburn, B Afsari, L Danilova, C Douville, ...
Science 359 (6378), 926-930, 2018
|TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal|
PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz, ...
Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013
|Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma|
S Jones, TL Wang, IM Shih, TL Mao, K Nakayama, R Roden, R Glas, ...
Science 330 (6001), 228-231, 2010
|Mutations in a signalling pathway|
Nature 436, 11, 2005
|Mutational analysis of the tyrosine phosphatome in colorectal cancers|
Z Wang, D Shen, DW Parsons, A Bardelli, J Sager, S Szabo, J Ptak, ...
Science 304 (5674), 1164-1166, 2004
|Notch signaling, γ-secretase inhibitors, and cancer therapy|
IM Shih, TL Wang
Cancer research 67 (5), 1879-1882, 2007
|Patterns of p53 mutations separate ovarian serous borderline tumors and low-and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a …|
G Singer, R Stöhr, L Cope, R Dehari, A Hartmann, DF Cao, TL Wang, ...
The American journal of surgical pathology 29 (2), 218-224, 2005
|Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene|
CH Chen, TL Wang, CF Hung, Y Yang, RA Young, DM Pardoll, TC Wu
Cancer research 60 (4), 1035-1042, 2000
|Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma|
KT Kuo, TL Mao, S Jones, E Veras, A Ayhan, TL Wang, R Glas, D Slamon, ...
The American journal of pathology 174 (5), 1597-1601, 2009
|Top-down morphogenesis of colorectal tumors|
IM Shih, TL Wang, G Traverso, K Romans, SR Hamilton, S Ben-Sasson, ...
Proceedings of the National Academy of Sciences 98 (5), 2640-2645, 2001
|MicroRNA expression and identification of putative miRNA targets in ovarian cancer|
N Dahiya, CA Sherman-Baust, TL Wang, B Davidson, IM Shih, Y Zhang, ...
PloS one 3 (6), e2436, 2008
|ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers|
B Guan, TL Wang, IM Shih
Cancer research 71 (21), 6718-6727, 2011
|High grade serous ovarian carcinomas originate in the fallopian tube|
SI Labidi-Galy, E Papp, D Hallberg, N Niknafs, V Adleff, M Noe, ...
Nature communications 8 (1), 1-11, 2017
|Cancer-associated mutations in endometriosis without cancer|
MS Anglesio, N Papadopoulos, A Ayhan, TM Nazeran, M Noë, ...
New England Journal of Medicine 376 (19), 1835-1848, 2017
|TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high‐grade serous carcinoma—evidence supporting the clonal relationship of the …|
E Kuhn, RJ Kurman, R Vang, AS Sehdev, G Han, R Soslow, TL Wang, ...
The Journal of pathology 226 (3), 421-426, 2012
|Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers|
RJ Leary, JC Lin, J Cummins, S Boca, LD Wood, DW Parsons, S Jones, ...
Proceedings of the National Academy of Sciences 105 (42), 16224-16229, 2008
TL Wang, C Maierhofer, MR Speicher, C Lengauer, B Vogelstein, ...
Proceedings of the National Academy of Sciences 99 (25), 16156-16161, 2002
|Highly enantioselective hydrogenation of quinolines using phosphine-free chiral cationic ruthenium catalysts: Scope, mechanism, and origin of enantioselectivity|
T Wang, LG Zhuo, Z Li, F Chen, Z Ding, Y He, QH Fan, J Xiang, ZX Yu, ...
Journal of the American Chemical Society 133 (25), 9878-9891, 2011
|Notch3 gene amplification in ovarian cancer|
JT Park, M Li, K Nakayama, TL Mao, B Davidson, Z Zhang, RJ Kurman, ...
Cancer research 66 (12), 6312-6318, 2006